Results 151 to 160 of about 22,921 (208)

Epigenetics of cancer : a new way to manage oncology patients [PDF]

, 2014
Martínez-Escardó, L., Universitat Autònoma de Barcelona. Facultat de Biociències   +1 more
core  

A Case of VEXAS Syndrome Initially Masked as Myelodysplastic Syndrome: Importance of Marrow Vacuolization and UBA1 Testing: A Case Report. [PDF]

Am J Case Rep
Shahverdi E, Mundmann P, Pohlkamp C, Dirare S, Hussein Mohamed I, Semerci H, Petz C.   +6 more
europepmc   +1 more source

Donor lymphocyte infusion combined with azacitidine after allogeneic HSCT in pediatric AML: a single-center retrospective analysis. [PDF]

Front Pharmacol
Bica AM, Marcu AD, Jercan CG, Iordan I, Serbanica AN, Avramescu I, Colita M, Popa DC, Constantinescu I, Ichim AM, Colita A, Colita A.   +11 more
europepmc   +1 more source

DNA methyltransferase inhibitors in hematological malignancies and solid tumors. [PDF]

Int J Cancer
Wenger V, Garcia-Manero G, Zeiser R, Lübbert M.   +3 more
europepmc   +1 more source

Azacitidine Beyond the Bone Marrow: An Unexpected Journey Into Azacitidine-Induced Arthropathy. [PDF]

Cureus
Bandyopadhyay S, Sahu A, Kumar Chandra S, Ghosh Dastidar A, Pratihar S.   +4 more
europepmc   +1 more source

15-Day Duration of Venetoclax Combined with Azacitidine in Treatment-Naive Higher-Risk Myelodysplastic Syndromes: A Prospective Multicenter Study. [PDF]

Cancers (Basel)
Lai B, Mei C, Yan X, Chen L, Wang Y, Sheng L, Tang S, Mao L, Zhang P, Sun Y, Xie W, Zhou, Mai W, Wang H, Ma L, Lou Y, Wu W, Jiang H, Zhang J, Ye B, Tong H, Ouyang G.   +21 more
europepmc   +1 more source

Life-Threatening Thrombotic Events Revealing Systemic Lupus Erythematosus in a Patient with Chronic Myelomonocytic Leukaemia. [PDF]

Eur J Case Rep Intern Med
Khadidja A, Salle V, Joris M, Schmidt J, Marolleau JP.   +4 more
europepmc   +1 more source

Superior response and survival of intensive chemotherapy over venetoclax plus azacitidine in newly diagnosed KIT-mutated acute myeloid leukemia. [PDF]

Ann Hematol
Ji Q, Jiang X, Li X, Cao C, Zhang X, Zhou M, Ma S, Chen C.   +7 more
europepmc   +1 more source

ALIDHE phase 3b study design: ivosidenib + azacitidine in adults with newly diagnosed <i>IDH1</i> mutant acute myeloid leukemia. [PDF]

Future Oncol
Vyas P, Salek S, Vives S, Recher C, Döhner H, Venditti A, Derrien H, Chatin S, De La Bigne AM, Pelouchova J, Hills R, Nier S.   +11 more
europepmc   +1 more source